{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-040179","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2026-04-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.871568+00:00","generated_at":"2026-05-15T07:24:01.378945+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Director Gaurav Aggarwal resigns from Unicycive board effective April 6","bullets":["Gaurav Aggarwal resigned from the Board of Directors on April 6, 2026.","Resignation was not due to any disagreement with the Company or management.","Company expressed gratitude for Dr. Aggarwal's service on the Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-040179","json":"https://secwatch.observer/filing/0001213900-26-040179.json","markdown":"https://secwatch.observer/filing/0001213900-26-040179.md","text":"https://secwatch.observer/filing/0001213900-26-040179.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390026040179/0001213900-26-040179-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390026040179/ea0285174-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:24:01.378945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}